Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves Amphotec

Nov. 27, 1996

FDA clears treatment for bulimia

Nov. 27, 1996

New biochemical marker for Alzheimer's disease identified

Nov. 27, 1996

First approval for Aricept

Nov. 27, 1996

Fujisawa antidementia agent in clinical stage

Nov. 27, 1996

Taiho antirheumatic agent possesses novel mechanism of action

Nov. 27, 1996

Potential drug screening invention available for licensing

Nov. 27, 1996

Children's Hospital of Philadelphia offers antimicrobial peptides for licensing

Nov. 27, 1996

Initial human safety studies completed for CoCensys' stroke drug

Nov. 27, 1996

Water-soluble fiber introduced in first market for high cholesterol

Nov. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...